Skip to main content
. 2020 Jul 29;20(4):59. doi: 10.3892/ol.2020.11920

Table V.

Univariate and multivariate analyses of prognostic factors for overall survival of patients with laryngeal squamous cell carcinoma.

Univariate analysis Multivariate analysis


Variables HR P-value 95% CI HR P-value 95% CI
Expression of MAGE-As, high vs. low 2.048 0.024a 1.099-3.816
Expression of MAGE-A1, high vs. low 1.948 0.068 0.951-3.990
Expression of MAGE-A2, high vs. low 2.297 0.014a 1.187-4.443 2.137 0.050 1.001-4.561
Expression of MAGE-A3, high vs. low 2.016 0.041a 1.028-3.954 1.207 0.731 0.412-3.540
Expression of MAGE-A4, high vs. low 2.131 0.046a 1.013-4.482 2.339 0.174 0.686-7.970
Expression of MAGE-A6, high vs. low 4.050 <0.001a 1.958-8.376 1.410 0.480 0.543-3.665
Expression of MAGE-A9, high vs. low 3.204 <0.001a 1.722-5.961 2.082 0.065 0.954-4.543
Expression of MAGE-A11, high vs. low 3.019 <0.001a 1.636-5.573 2.438 0.032a 1.080-5.504
Age, years, <60 vs. ≥60 1.369 0.327 0.730-2.566
Tumor location, supraglottic vs. glottic 1.839 0.053 0.992-3.409
Smoking index, <400 vs. ≥400 1.335 0.381 0.700-2.547
Tumor size, cm, <2 vs. ≥2 1.924 0.057 0.981-3.777
Histological grade, G1/G2 vs. G3 2.013 0.028a 1.078-3.760 1.290 0.544 0.568-2.931
Clinical stage (AJCC), I/II vs. III/IV 2.345 0.013a 1.194-4.604
Metastatic state of lymph node, N vs. N0 10.788 <0.001a 5.036-23.110 21.112 <0.001a 7.927-56.226
a

P<0.05. MAGE, melanoma-associated antigen; HR, hazard ratio; CI, confidence interval; N, patients with lymph node metastasis; AJCC, American Joint Committee on Cancer.